LENZ Therapeutics Inc (LENZ)

Currency in USD
14.22
+0.25(+1.79%)
Closed·
14.220.00(0.00%)
·

LENZ Income Statement

Period Ending:
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
* In Millions of USD (except for per share items)

FAQ

How much revenue did LENZ Therapeutics report in the most recent quarter?

In its most recent quarterly earnings report, LENZ Therapeutics posted revenue of 12.50.

What was LENZ Therapeutics’s net income for the year?

For the full year, LENZ Therapeutics reported net income of -49.77.

How much net income did LENZ Therapeutics post in the last quarter?

In the most recent quarter, LENZ Therapeutics (LENZ) posted net income of -16.70.

How much gross profit did LENZ Therapeutics generate last quarter?

LENZ Therapeutics recorded gross profit of 12.50 in its latest quarterly report.

What was LENZ Therapeutics’s annual operating income?

For the full year, LENZ Therapeutics (LENZ) reported operating income of -58.61.

What was LENZ Therapeutics’s operating income last quarter?

Quarterly operating income was -18.89.

What was LENZ Therapeutics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -18.76.

What was the quarter-over-quarter change in EBITDA for LENZ Therapeutics?

EBITDA changed by -11.43% compared to the last quarter.

What is LENZ Therapeutics’s most recent gross profit margin?

The latest reported gross profit margin for LENZ Therapeutics (LENZ) is 100.00%.

What is LENZ Therapeutics’s most recent net income margin?

Net income margin based on recent financials is -133.60%.

What is LENZ Therapeutics’s most recent EBIT margin?

LENZ Therapeutics reported an EBIT margin of -151.10% based on current figures.

How did LENZ Therapeutics’s revenue change compared to the previous quarter?

Revenue changed by 150.00% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for LENZ Therapeutics?

In the latest quarter 2026, gross profit changed by 150.00% from the previous quarter.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.